Market Overview:
The global human milk oligosaccharides in infant formula market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth of this market can be attributed to the increasing demand for premium and organic infant formulas, rising awareness about the benefits of human milk oligosaccharides for infants, and growing number of working women. However, stringent regulatory norms regarding the use of additives in infant formulas may restrain the growth of this market to some extent. On the basis of type, 2’FL is projected to be the fastest-growing segment during the forecast period from 2018 to 2030. This can be attributed to its high nutritional value and health benefits for infants.
Product Definition:
Human Milk Oligosaccharides (HMO) are a type of prebiotic that play an important role in the development and health of infants. They are not found in cow's milk or other animal milks, but are present in human breast milk. HMOs help to promote the growth of beneficial bacteria in the gut, which can support good health throughout life. They also help to protect infants from infection and may improve cognitive development.
2’FL:
2'FL is the second most abundant form of human milk oligosaccharides (HMO). It was first detected in human milk and has been identified as one of the factors that contribute to its high levels found in breast-fed infants. 2'FL is a type of HMO, which can be distinguished from other forms by its chemical structure.
3’FL:
3' - Flucosidase is an enzyme, which hydrolyzes lactose to form galactose and fructose. Human milk contains a high concentration of 3' - flucosidase (10-15% of total protein) that efficiently catalyzes the hydrolysis of lactose into various monosaccharides.
Application Insights:
On the basis of application, the global infant formula market has been segmented into infant formula, functional food & beverages, food/medical supplements and other applications. The infant formula segment accounted for more than 50% of the overall share in 2017. This is attributed to increasing demand for specific composition baby formulas that are designed to meet individual needs of infants.
Functional foods & beverages is expected to be one of the fastest-growing segments over the forecast period owing to rising consumer awareness regarding health benefits associated with these products coupled with a growing preference for healthy lifestyle practices among consumers globally.
Food/medical supplements are expected to witness significant growth over next six years due largely on increased product usage as nutritional support in disease management.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to high demand for human milk oligosaccharides and increasing awareness about their benefits. In addition, growing number of product launches in U.S., due to increased consumer preference for natural products, is also one of the major factors driving growth in this region.
Major players operating in this industry include Danone S.A.; Abbott; Mead Johnson & Company; Horizon Organic Dairy Inc.; WhiteWave Foods Co-operative; Avantor Performance Materials Inc.; Earth's Own Milk Ltd.
Growth Factors:
- Increasing awareness about the benefits of human milk oligosaccharides in infant formula among parents and healthcare professionals.
- Rising demand for organic and premium infant formulas that contain human milk oligosaccharides.
- Growing number of women who are choosing to breastfeed their infants for health benefits, which is driving the demand for human milk oligosaccharides in infant formula products.
- increasing research on the benefits of human milk oligosaccharides in infant formula, which is likely to result in more product launches over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Milk Oligosaccharides in Infant Formula Market Research Report
By Type
2’FL, 3’FL, 3’SL, 6’SL
By Application
Infant Formula, Functional Food & Beverages, Food/Medical Supplements, Other
By Companies
Abbott, BASF, Dextra Laboratories, DuPont, Elicityl, Glycom, Glycosyn, Inbiose, Jennewein Biotechnologie, Nestle Health Science, Zuchem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Human Milk Oligosaccharides in Infant Formula Market Report Segments:
The global Human Milk Oligosaccharides in Infant Formula market is segmented on the basis of:
Types
2’FL, 3’FL, 3’SL, 6’SL
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Infant Formula, Functional Food & Beverages, Food/Medical Supplements, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- BASF
- Dextra Laboratories
- DuPont
- Elicityl
- Glycom
- Glycosyn
- Inbiose
- Jennewein Biotechnologie
- Nestle Health Science
- Zuchem
Highlights of The Human Milk Oligosaccharides in Infant Formula Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2’FL
- 3’FL
- 3’SL
- 6’SL
- By Application:
- Infant Formula
- Functional Food & Beverages
- Food/Medical Supplements
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Milk Oligosaccharides in Infant Formula Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human milk oligosaccharides are a type of sugar that is found in human milk. These sugars help to feed the baby and provide them with important nutrients.
Some of the major companies in the human milk oligosaccharides in infant formula market are Abbott, BASF, Dextra Laboratories, DuPont, Elicityl, Glycom, Glycosyn, Inbiose, Jennewein Biotechnologie, Nestle Health Science, Zuchem.
The human milk oligosaccharides in infant formula market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human Milk Oligosaccharides in Infant Formula Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Human Milk Oligosaccharides in Infant Formula Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Human Milk Oligosaccharides in Infant Formula Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Human Milk Oligosaccharides in Infant Formula Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Human Milk Oligosaccharides in Infant Formula Market Size & Forecast, 2020-2028
4.5.1 Human Milk Oligosaccharides in Infant Formula Market Size and Y-o-Y Growth
4.5.2 Human Milk Oligosaccharides in Infant Formula Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 2’FL
5.2.2 3’FL
5.2.3 3’SL
5.2.4 6’SL
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Infant Formula
6.2.2 Functional Food & Beverages
6.2.3 Food/Medical Supplements
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Human Milk Oligosaccharides in Infant Formula Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Human Milk Oligosaccharides in Infant Formula Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 2’FL
9.6.2 3’FL
9.6.3 3’SL
9.6.4 6’SL
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Infant Formula
9.10.2 Functional Food & Beverages
9.10.3 Food/Medical Supplements
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 2’FL
10.6.2 3’FL
10.6.3 3’SL
10.6.4 6’SL
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Infant Formula
10.10.2 Functional Food & Beverages
10.10.3 Food/Medical Supplements
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 2’FL
11.6.2 3’FL
11.6.3 3’SL
11.6.4 6’SL
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Infant Formula
11.10.2 Functional Food & Beverages
11.10.3 Food/Medical Supplements
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 2’FL
12.6.2 3’FL
12.6.3 3’SL
12.6.4 6’SL
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Infant Formula
12.10.2 Functional Food & Beverages
12.10.3 Food/Medical Supplements
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 2’FL
13.6.2 3’FL
13.6.3 3’SL
13.6.4 6’SL
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Infant Formula
13.10.2 Functional Food & Beverages
13.10.3 Food/Medical Supplements
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Human Milk Oligosaccharides in Infant Formula Market: Competitive Dashboard
14.2 Global Human Milk Oligosaccharides in Infant Formula Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 BASF
14.3.3 Dextra Laboratories
14.3.4 DuPont
14.3.5 Elicityl
14.3.6 Glycom
14.3.7 Glycosyn
14.3.8 Inbiose
14.3.9 Jennewein Biotechnologie
14.3.10 Nestle Health Science
14.3.11 Zuchem
